Adicet Bio Inc at Jefferies Cell Therapy Summit Transcript
Welcome, everyone, to the Jefferies Cell Therapy Summit. I'd like to welcome our next company. We have Adicet Bio, their CEO, Chen Schor; and their Chief Scientific Officer, Stewart Abbot. So welcome guys. We've got about 25 minutes. This is going to be a fireside chat format. (Operator Instructions).
Just for those that aren't familiar with Adicet, recently became public through a reverse merger. Maybe, Chen, just talk about high-level pipeline, objective in cell therapy, what you're hoping to accomplish and then we can go into specific programs.
Absolutely. So first of all, Biren, thank you so much for inviting us. I mean, it's especially great to be here with your expertise in the field of cell therapy. So perhaps I'll give a brief background about gamma delta T cells and brief about the pipeline.
So yes -- gamma delta T cells, the first important piece of evidence actually comes from an
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
